Ikena Oncology
Patents, Design & Utilities

Last updated:

List of all Ikena Oncology patents 11 in total

Status Patent
Application
Utility: TEAD INHIBITORS AND USES THEREOF External link
Filling date: 7 Sep 2025 Issue date: 11 Aug 2022
Grant
Utility: Indole AHR inhibitors and uses thereof External link
Filling date: 7 Sep 2025 Issue date: 14 Jun 2022
Application
Utility: INDOLE AHR INHIBITORS AND USES THEREOF External link
Filling date: 7 Sep 2025 Issue date: 12 May 2022
Grant
Utility: Tead inhibitors and uses thereof External link
Filling date: 7 Sep 2025 Issue date: 15 Mar 2022
Application
Utility: ARYL HYDROCARBON RECEPTOR (AHR) AGONISTS AND USES THEREOF External link
Filling date: 7 Sep 2025 Issue date: 30 Sep 2021
Application
Utility: POLYMORPHIC COMPOUNDS AND USES THEREOF External link
Filling date: 7 Sep 2025 Issue date: 19 Aug 2021
Application
Utility: ARYL HYDROCARBON RECEPTOR (AHR) AGONISTS AND USES THEREOF External link
Filling date: 7 Sep 2025 Issue date: 29 Jul 2021
Application
Utility: PEGYLATED KYNURENINASE ENZYMES AND USES THEREOF FOR THE TREATMENT OF CANCER External link
Filling date: 7 Sep 2025 Issue date: 22 Apr 2021
Application
Utility: AHR INHIBITORS AND USES THEREOF External link
Filling date: 7 Sep 2025 Issue date: 21 Jan 2021
Application
Utility: TEAD INHIBITORS AND USES THEREOF External link
Filling date: 7 Sep 2025 Issue date: 31 Dec 2020
Application
Utility: INDOLE AHR INHIBITORS AND USES THEREOF External link
Filling date: 7 Sep 2025 Issue date: 22 Oct 2020

Showing 1 to 11 of 11 patents.